 Eight years of expertise in formulation and pre-formulation research on compounds of pharmaceutical interest  Expertise in bioavailability enhancement of poorly soluble compounds via various techniques (lyophilization, spray drying, nanotechnology, etc)  Expertise in nano-suspension development (long acting and fast solubilization)  Experience managing CRO/CMO  Strong laboratory skills and expertise; extensive hands-on analytical experience：PSD, HPLC, DSC, TGA, PXRD, DVS, NMR, IR, SEM, and Optical Microscopy  Proven ability providing elegant solutions to complex problems  Excellent interpersonal skills; respectful of diversity  Highly motivated; results oriented; team player

Senior Formulations Scientist @ Motivated senior formulation scientist to oversee the timely delivery of drug products to support the Company’s clinical studies.  Drives formulation development, optimization, and production using rational design and data analysis  Leads the validation strategy for the commercialization of drug product production  Executes technical transfers, scale up, and clinical manufacture at CMOs  Writes and reviews technical reports, including regulatory filing source documents  Preparation of IND and NDA CMC sections  Prepares and presents experimental conclusions at various technical meetings  Assists with clinical trial material packaging, labeling and distribution. From November 2015 to Present (2 months) Scientist 2 (Formulation) @ • Co-led a controlled release intra-articular injection project; changed leadership’s opinion and revived this terminated project • Led nano IV formulation feasibility studies; enabled a strategic decision-making at company-scale • Provided formulation support to significantly improve oral bioavailability of a BCS Class III compound • Participated a lyo-formulation optimization project for a combo IV product From January 2013 to May 2015 (2 years 5 months) Greater Boston AreaScientist III @ • Led the life cycle management of ALKS 9070 program: long acting nano-suspension • Led pharmaceutical evaluations of multiple new chemical entities o Develop formulation strategy to provide the target release profiles o Conduct API form-discovery, form-selection, and salt screening and support pre-clinical studies From March 2008 to December 2012 (4 years 10 months) Greater Boston AreaResearch Investigator @ • Led the development of polymer based anti-HIV/contraceptive combo products for vaginal use • Conducted Carraguard® stability studies for phase III clinical trial • Directly managed one employee; ensured he was fully competent and capable of outstanding performance. From January 2006 to February 2008 (2 years 2 months) Greater New York City Area

Doctor of Philosophy (Ph.D.), Organic Chemistry @ University of Oklahoma From 2000 to 2005 Bachelor’s Degree, General chemistry @ Nanjing University From 1994 to 1998 Richard Hu is skilled in: HPLC, Drug Discovery, Chromatography, UV/Vis, DMPK, DSC, Poorly soluble Compound, Solid State Characterization, Nano Suspension, Lyophilization, IR, PXRD, CRO, CMO, DVS